Vaccine therapy for pancreatic cancer
Pancreatic cancer is a lethal disease and currently available therapies have significant
limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment …
limitations. Pancreatic cancer is thus an ideal setting for the development of novel treatment …
[PDF][PDF] Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature
G Garcea, AR Dennison, CJ Pattenden, CP Neal… - Jop, 2008 - researchgate.net
Context Patients with resectable pancreatic cancer comprise a small subgroup of the overall
population with the disease from around 15 to 20%, with nearly all patients dying from their …
population with the disease from around 15 to 20%, with nearly all patients dying from their …
[HTML][HTML] The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
A Bengtsson, R Andersson, D Ansari - Scientific reports, 2020 - nature.com
Survival data for pancreatic cancer are usually based on actuarial calculations and actual
long-term survival rates are rarely reported. Here we use population-level data from the …
long-term survival rates are rarely reported. Here we use population-level data from the …
1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience
JM Winter, JL Cameron, KA Campbell… - Journal of …, 2006 - Springer
Pancreaticoduodenectomy (PD) with the possible addition of neoadjuvant or adjuvant
therapy is the standard of care in the United States for adenocarcinoma originating in the …
therapy is the standard of care in the United States for adenocarcinoma originating in the …
CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942
The detailed biological functions of circular RNA (circRNA) are largely unexplored. Using
circRNA sequencing, we identified 169 differentially expressed circRNA in pancreatic ductal …
circRNA sequencing, we identified 169 differentially expressed circRNA in pancreatic ductal …
[HTML][HTML] Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study
H Wang, J Liu, G Xia, S Lei, X Huang, X Huang - Scientific reports, 2020 - nature.com
In this population-based retrospective study, we aimed to investigate the association
between age at diagnosis and prognosis of pancreatic cancer (PC) patients using data from …
between age at diagnosis and prognosis of pancreatic cancer (PC) patients using data from …
Pancreatic resection for M1 pancreatic ductal adenocarcinoma
Background Improved safety of pancreatic surgery has led to consideration of more
aggressive approaches, such as resection for primary pancreatic ductal adenocarcinoma …
aggressive approaches, such as resection for primary pancreatic ductal adenocarcinoma …
[HTML][HTML] Iron oxide nanoparticle-based hyperthermia as a treatment option in various gastrointestinal malignancies
Iron oxide nanoparticle-based hyperthermia is an emerging field in cancer treatment. The
hyperthermia is primarily achieved by two differing methods: magnetic fluid hyperthermia …
hyperthermia is primarily achieved by two differing methods: magnetic fluid hyperthermia …
[HTML][HTML] Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010
H Sun, H Ma, G Hong, H Sun, J Wang - Scientific reports, 2014 - nature.com
Pancreatic cancer (PaCa) is an aggressive malignancy with a high mortality rate and a poor
prognosis. To evaluate treatment outcomes of patients with pancreatic cancer over the past …
prognosis. To evaluate treatment outcomes of patients with pancreatic cancer over the past …
Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
S Karakhanova, J Link, M Heinrich… - …, 2015 - Taylor & Francis
Pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest cancers in the
world. PDAC cells activate tumor-specific immune responses but simultaneously trigger a …
world. PDAC cells activate tumor-specific immune responses but simultaneously trigger a …